Harrys Torres is an Infectious Disease provider in Houston, Texas. Dr. Torres is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, and Hepatitis E.

Anuj Gaggar is an Infectious Disease provider in San Francisco, California. Dr. Gaggar is rated as an Elite provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis B, Hepatitis, Hepatitis C, and Sepsis.

Pamela Warnick is an Infectious Disease provider in Chicago, Illinois. Dr. Warnick is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Myelitis, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, and HIV/AIDS.

Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and her fellowship in infectious diseases at Johns Hopkins. Her research interests include chronic hepatitis B and C and coinfection of viral hepatitis with HIV/AIDS. She has developed a program centered around virology and immunology translational work towards an HBV cure. Dr. Thio is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America. Dr. Thio is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and HIV/AIDS.

Gibril Ndow is an Infectious Disease expert in Banjul, Gambia. Mr. Ndow is rated as a Distinguished expert by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis B, Hepatitis, Herpes Virus Antenatal Infection, and Hepatitis C.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Oidov Baatarkhuu is an Infectious Disease expert in Ulan Bator, Mongolia. Mr. Baatarkhuu is rated as a Distinguished expert by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Hepatitis A, and Hepato-Pancreato-Biliary Surgery.

Nicolas Barros-Baertl is an Infectious Disease provider in Indianapolis, Indiana. Dr. Barros-Baertl is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Cryptococcosis, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Pneumocystis Jiroveci Pneumonia. Dr. Barros-Baertl is currently accepting new patients.

Costi Sifri is an Infectious Disease provider in Charlottesville, Virginia. Dr. Sifri is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Nocardiosis, and Febrile Neutropenia. Dr. Sifri is currently accepting new patients.

Michael Vinikoor is an Infectious Disease provider in Birmingham, Alabama. Dr. Vinikoor is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis B, HIV/AIDS, Hepatitis, and Herpes Virus Antenatal Infection. Dr. Vinikoor is currently accepting new patients.

Susanna Tan is an Infectious Disease provider in Stanford, California. Dr. Tan is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis B, Hepatitis, Cytomegalovirus Infection, and Cytomegalic Inclusion Disease.

Ronald Nahass is an Infectious Disease provider in Hillsborough, New Jersey. Dr. Nahass is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, and Lyme Disease.

Yamini Kalla is an Infectious Disease provider in Abilene, Texas. Dr. Kalla is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis B, Hepatitis, Infectious Arthritis, and Streptococcal Group B Infection. Dr. Kalla is currently accepting new patients.

Jimmy Chua is an Infectious Disease provider in Lewes, Delaware. Dr. Chua is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Lymphangitis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Osteomyelitis, and Hepatitis B. Dr. Chua is currently accepting new patients.

Amir Mohareb is an Infectious Disease provider in Boston, Massachusetts. Dr. Mohareb is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis B, Hepatitis, COVID-19, and Febrile Neutropenia. Dr. Mohareb is currently accepting new patients.

Joseph Mcgowan is an Infectious Disease provider in Manhasset, New York. Dr. Mcgowan is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Andrzej Horban is an Infectious Disease expert in Warsaw, Poland. Mr. Horban is rated as an Advanced expert by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Hepatitis, Hepatitis C, and Hepatitis B.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B.

Joseph Tucker is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Tucker is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Syphilis, HIV/AIDS, Gonorrhea, and COVID-19. Dr. Tucker is currently accepting new patients.